90/015,776MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS8,637,061Open

Status

Final Action Mailed

Filed

Dec 12, 2025

Last Updated

Aug 21, 2026

Art Unit

3991

Requester

Unknown

Requester Law Firm

Bayes, PLLC

Requested By

Third Party

Patent Owner

Neurocentria Inc.

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

424Drug, Bio-Affecting And Body Treating Compositions

Reexam History (34 events)

Aug 21, 2026MRXFRRX - Mail Final Rejection
Aug 4, 2026RXLET.Miscellaneous Incoming Letter
Aug 4, 2026RXC/SRCertificate of Service
Aug 4, 2026RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Aug 4, 2026RXA...Response after Non-Final Action
Jun 29, 2026MRXG.RX - Mail Extension of Time Period for Response Granted
Jun 29, 2026MREXNRX - Mail Examiner Interview Summary Record
Jun 25, 2026RXRQ/TRequest for Extension of Time
Jun 25, 2026RXC/SRCertificate of Service
Jun 10, 2026PA..Change in Power of Attorney (May Include Associate POA)
May 4, 2026MR.NFRX - Mail Reexam Non-Final Action
Mar 27, 2026RCCPRX - Concurrent Proceedings Notice
Mar 25, 2026RXFWDXDate Forwarded to Examiner
Jan 13, 2026MREXORX - Mail Ex Parte Request for Reexamination Granted
Dec 23, 2025IDSCInformation Disclosure Statement considered
Dec 19, 2025MRXNReexamination Formalities Notice Mailed
Dec 19, 2025MRXNReexamination Formalities Notice Mailed
Dec 19, 2025DOCKCase Docketed to Examiner in GAU
Dec 19, 2025COMPApplication Is Now Complete
Dec 18, 2025SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Dec 18, 2025RXTTLRPTTitle Report
Dec 18, 2025RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Dec 18, 2025RXNREQFDNotice of reexamination request filing date
Dec 18, 2025RXNREQAUNotice of assignment of reexamination request
Dec 15, 2025RXLITSRReexam Litigation Search Conducted
Dec 15, 2025PRXRParalegal Reexam Review Complete
Dec 15, 2025FTFIFITF set to NO - revise initial setting
Dec 12, 2025WIDSInformation Disclosure Statement (IDS) Filed
Dec 12, 2025WIDSInformation Disclosure Statement (IDS) Filed
Dec 12, 2025RXOSUBReceipt of Original Ex Parte Reexam Request
Dec 12, 2025RXO_40.RReceipt of Orig. Ex Parte Request by Third Party Less Than 40 Pages - Rule 1.20(c )(1)
Dec 12, 2025RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Dec 12, 2025RXC/SRCertificate of Service
Dec 12, 2025BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedMar 1, 2013

Prosecution History

DateCodeDescription
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Jan 28, 2014
3.5-yr
Jul 28, 2017
7.5-yr
Jul 28, 2021
Paid Jul 28, 2021
11.5-yr
Jul 28, 2025
Paid Jul 16, 2025
Expiry
Feb 22, 2032

Entity Status

Large Entity

Expires

Feb 22, 2032 (5.9 yr remaining)

Assignments

2009201020112012201320142015FiledGUOSONG LIUFEI MAOMAGCEUTICS, INC.NEUROCENTRIA, INC.
AssignmentReel/Frame: 027825/0773Recorded: Mar 8, 2012

From

GUOSONG LIUInventor
Jun 10, 2008
FEI MAOInventor
Jun 10, 2008

To

MAGCEUTICS, INC.

Name ChangeReel/Frame: 038315/0295Recorded: Apr 19, 2016

From

MAGCEUTICS, INC.
Jul 8, 2015

To

NEUROCENTRIA, INC.